The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature
Mark Kacar,1 Sinisa Savic,1 Jeroen CH van der Hilst2,3 1Department of Clinical Immunology and Allergy, St James´s University Hospital, Leeds, UK; 2Department of Infectious Diseases and Immunity, Jessa Hospital, Hasselt, Belgium; 3BIOMED Research Institute, University of Hasselt, Hasselt, B...
Saved in:
Main Authors: | Kacar M (Author), Savic S (Author), van der Hilst JCH (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Canakinumab as rescue therapy in familial Mediterranean fever refractory to conventional treatment
by: Alpa M, et al.
Published: (2015) -
Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases
by: Burcu Bozkaya Yücel, et al.
Published: (2021) -
Two Sisters with Colchicine-Resistant form of Familial Mediterranean Fever on the Canakinumab Therapy: Clinical Case
by: Elena A. Ligostaeva, et al.
Published: (2020) -
Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience
by: Gülşah Kavrul Kayaalp, et al.
Published: (2023) -
Familial Mediterranean Fever in Childhood
by: Rabia Miray Kisla Ekinci, et al.
Published: (2024)